Ten Cate Liesbeth, Herregods Thomas V K, Dejonckere Philippe H, Hemmink Gerrit J M, Smout André J P M, Bredenoord Albert J
Stem en Spraak (Voice and Speech), Logopedie aan de Amstel, Herengracht 500, 1017 CB, Amsterdam, The Netherlands.
Department of Gastroenterology and Hepatology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Dysphagia. 2018 Oct;33(5):707-715. doi: 10.1007/s00455-018-9890-y. Epub 2018 Mar 24.
The purpose of this study was to describe a newly developed speech therapy program as an innovating therapeutic approach and to assess the results of this intervention in patients with supragastric belching. This is a retrospective analysis of prospectively gathered data from 73 patients with supragastric belching who were treated with speech therapy between 2007 and 2017. Of these, 48 were included for evaluation of therapy. Thirty patients had supragastric belching proven by 24-h impedance measurements. Eighteen patients were diagnosed by an experienced speech language pathologist as having supragastric belching according to precise criteria. Speech therapy consists of explanation, creating awareness of esophageal air influx and exercises to discontinue the supragastric belching mechanism. Therapy effect was measured by comparing visual analogue scale (VAS) scores on belching and related symptoms. The median symptom duration at the start of therapy was 2 years. Supragastric belching symptoms decreased significantly with a total median VAS score of 406 (291-463) prior to treatment and a median VAS score of 125 (17-197) following treatment. Forty patients (83%) had a sufficient to major result with a median therapy duration of 3 months and ten sessions. Speech therapy was an effective treatment in the majority of patients with supragastric belching.
本研究的目的是描述一种新开发的言语治疗方案，作为一种创新的治疗方法，并评估该干预措施对嗳气患者的治疗效果。这是一项对2007年至2017年间接受言语治疗的73例嗳气患者前瞻性收集数据的回顾性分析。其中，48例纳入治疗效果评估。30例患者经24小时阻抗测量证实存在嗳气。18例患者由经验丰富的言语病理学家根据精确标准诊断为嗳气。言语治疗包括解释、提高对食管气体流入的认识以及停止嗳气机制的练习。通过比较嗳气及相关症状的视觉模拟量表（VAS）评分来衡量治疗效果。治疗开始时症状的中位持续时间为2年。嗳气症状显著减轻，治疗前VAS总评分中位数为406（291 - 463），治疗后为125（17 - 197）。40例患者（83%）取得了充分至显著的治疗效果，中位治疗持续时间为3个月，共10次治疗。言语治疗对大多数嗳气患者是一种有效的治疗方法。
